Vernon, Suzanne D, Whistler, Toni, Aslakson, Eric et al. · Pharmacogenomics · 2006 · DOI
This paper discusses why it's been difficult for scientists to find reliable blood tests (biomarkers) to diagnose ME/CFS and develop treatments. The authors explain that ME/CFS is complex because it affects many body systems at once, and each researcher may focus on different areas based on their expertise. They suggest that blood tests show promise for understanding ME/CFS and that combining genetic information, protein data, and information about patients' environments and behaviors could help researchers better understand why different patients experience the illness differently.
This work provides a critical framework for understanding why ME/CFS biomarker research has progressed slowly despite decades of effort. For patients, recognizing these scientific challenges validates the complexity of their condition and explains why a single diagnostic test remains elusive. For researchers, this paper outlines a roadmap for future studies by emphasizing the necessity of multi-system, multi-modal data integration rather than siloed investigations.
This paper does not identify any specific biomarkers or prove what causes ME/CFS. It does not present new experimental data or demonstrate that any particular diagnostic approach will succeed. It is a conceptual analysis of methodological challenges rather than evidence that any particular intervention or diagnostic strategy works.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Vernon, Suzanne D, Whistler, Toni, Aslakson, Eric, Rajeevan, Mangalathu, & Reeves, William C (2006). Challenges for molecular profiling of chronic fatigue syndrome.. Pharmacogenomics. https://doi.org/10.2217/14622416.7.2.211
BibTeX
@article{mecfsatlas-vernon-2006-challenges-molecular,
author = {Vernon, Suzanne D and Whistler, Toni and Aslakson, Eric and Rajeevan, Mangalathu and Reeves, William C},
title = {Challenges for molecular profiling of chronic fatigue syndrome.},
journal = {Pharmacogenomics},
year = {2006},
doi = {10.2217/14622416.7.2.211},
note = {PubMed: 16515400},
url = {https://www.mecfsatlas.com/evidence/vernon-2006-challenges-molecular},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-30. https://www.mecfsatlas.com/evidence/vernon-2006-challenges-molecular
Contribute
Private, reviewed by a human. Not a public comment thread.